These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32702730)

  • 1. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data.
    Das S; Camphausen K; Shankavaram U
    Res Sq; 2020 Jun; ():. PubMed ID: 32702730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
    Loganathan T; Ramachandran S; Shankaran P; Nagarajan D; Mohan S S
    PeerJ; 2020; 8():e9357. PubMed ID: 32566414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach.
    Gelemanović A; Vidović T; Stepanić V; Trajković K
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33504008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An
    Alexpandi R; De Mesquita JF; Pandian SK; Ravi AV
    Front Microbiol; 2020; 11():1796. PubMed ID: 32793181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
    Chatterjee SK; Saha S; Munoz MNM
    Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Asano T; Chelvanambi S; Decano JL; Whelan MC; Aikawa E; Aikawa M
    Front Cardiovasc Med; 2022; 9():842641. PubMed ID: 35402570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Identification of Druggable Targets and the Power of the PHENotype SIMulator for Effective Drug Repurposing in COVID-19.
    Maria NI; Rapicavoli RV; Alaimo S; Bischof E; Stasuzzo A; Broek JAC; Pulvirenti A; Mishra B; Duits AJ; Ferro A
    Res Sq; 2021 Apr; ():. PubMed ID: 33880466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics.
    Liu DY; Liu JC; Liang S; Meng XH; Greenbaum J; Xiao HM; Tan LJ; Deng HW
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33919660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data.
    Alakwaa FM
    mSystems; 2020 Apr; 5(2):. PubMed ID: 32291351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.
    Cafiero C; Re A; Micera A; Palmirotta R; Monaco D; Romano F; Fabrizio C; Di Francia R; Cacciamani A; Surico PL; D'Amato G; Pisconti S
    Pharmgenomics Pers Med; 2020; 13():463-484. PubMed ID: 33116761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
    Crespo-Facorro B; Ruiz-Veguilla M; Vázquez-Bourgon J; Sánchez-Hidalgo AC; Garrido-Torres N; Cisneros JM; Prieto C; Sainz J
    Front Pharmacol; 2021; 12():646701. PubMed ID: 33762960
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS.
    O'Donovan SM; Eby H; Henkel ND; Creeden J; Imami A; Asah S; Zhang X; Wu X; Alnafisah R; Taylor RT; Reigle J; Thorman A; Shamsaei B; Meller J; McCullumsmith RE
    Res Sq; 2020 Apr; ():. PubMed ID: 32702077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting inconsistency in large pharmacogenomic studies.
    Safikhani Z; Smirnov P; Freeman M; El-Hachem N; She A; Rene Q; Goldenberg A; Birkbak NJ; Hatzis C; Shi L; Beck AH; Aerts HJWL; Quackenbush J; Haibe-Kains B
    F1000Res; 2016; 5():2333. PubMed ID: 28928933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
    Liu TP; Hsieh YY; Chou CJ; Yang PM
    R Soc Open Sci; 2018 Nov; 5(11):181321. PubMed ID: 30564416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational-based drug repurposing methods in COVID-19.
    Masoudi-Sobhanzadeh Y
    Bioimpacts; 2020; 10(3):205-206. PubMed ID: 32793443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach.
    Prabhu NB; Vinay CM; Satyamoorthy K; Rai PS
    3 Biotech; 2022 Nov; 12(11):287. PubMed ID: 36164436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19" [Infection, Genetics and Evolution 103 (2022) 105318].
    Mirmohammadi SM; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheikharabi M; Bazzi Z
    Infect Genet Evol; 2022 Oct; 104():105361. PubMed ID: 36089457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modulation of transcriptomic signature of the infected host: a new therapeutic strategy for the management of severe viral infections? Example of the flu].
    Poissy J; Terrier O; Lina B; Textoris J; Rosa-Calatrava M
    Reanimation; 2016; 25(Suppl 2):53-61. PubMed ID: 32288744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments.
    Hamed AA; Fandy TE; Tkaczuk KL; Verspoor K; Lee BS
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of pharmacogenomic agreement.
    Safikhani Z; El-Hachem N; Quevedo R; Smirnov P; Goldenberg A; Juul Birkbak N; Mason C; Hatzis C; Shi L; Aerts HJ; Quackenbush J; Haibe-Kains B
    F1000Res; 2016; 5():825. PubMed ID: 27408686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.